New York, NY -- (SBWIRE) -- 01/27/2016 -- Actinium Pharmaceuticals, Inc.("Actinium"), is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today the appointment of Rowena Choudrie, M.S. to the position of Senior Director, Pharmaceutical Product Development and Kevin Zikaras to the position of Senior Clinical Scientist. These hires will report to Kaushik J. Dave, Ph.D., MBA Chief Executive Officer and Felix Garzon, M.D., Ph.D., Senior Vice President, Head of Clinical Development, respectively.
Read the full press release at http://www.sbwire.com/press-releases/actinium-pharmaceuticals-announces-new-hires-to-product-development-and-clinical-research-teams-660237.htm
